COVID-19 and epilepsy: Russian and international experience
Abstract
This article reviews the issues of epilepsy course in patients with COVID-19 and predictors of the worsening of the course of the disease in the context of the COVID-19 pandemic. Risk of seizures associated with COVID-19 is relatively low both in patients with epilepsy and in general population, with the exception of critically and terminally ill patients. Studies that evaluated the impact of the COVID-19 pandemic on the condition of patients with epilepsy are characterized by complex medical, social and pathophysiological approaches to the problem. Predictors of negative epilepsy dynamics in the context of the COVID-19 pandemic include drug interactions between antiepileptic drugs (AEDs) and drugs used to treat COVID-19; disruption of AEDs supply; stress in patients; comorbid somatic pathology.
Keywords
About the Author
G. V. Odintsova
Prof. A.L. Polenov Russian Research Neurosurgical Institute – Branch of V.A. Almazov National Medical Research Center, Ministry of Health of Russia
Russian Federation
Russian Federation
Galina Vyacheslavovna Odintsova
12, Mayakovskogo St., Saint-Petersburg 191014
References
1. Huang S, Wu C, Jia Y, et al. COVID-19 outbreak: The impact of stress on seizures in patients with epilepsy. Epilepsia. 2020 Sep;61(9):1884-93. doi: 10.1111/epi.16635. Epub 2020 Aug 6.
2. Smok AM, Malkova AM, Kudlay DA, Starshinova AA. Possibilities for correcting hepatotoxic reactions during therapy in patients with COVID-19 (case report). Translyatsionnaya meditsina = Translational Medicine. 2020;7(6):65-72. doi: 10.18705/2311-4495-2020-7-6-65-72 (In Russ.).
3. Starshinova AA, Kushnareva EA, Kudlay DA, Dovgalyuk IF. Prospects for a COVID-19 treatment: review. Translyatsionnaya meditsina = Translational Medicine. 2020;7(3):30-7. doi: 10.18705/2311-4495-2020-7-3-30-37 (In Russ.).
4. Ternovykh IK, Topuzova MP, Chaykovskaya AD, et al. Neurological manifestations and complications in patients with COVID-19. Translyatsionnaya meditsina = Translational Medicine. 2020;7(3):21-9. doi: 10.18705/2311-4495-2020-7-3-21-29 (In Russ.).
5. Vohora D, Jain S, Tripathi M, Potschka H. COVID-19 and seizures: Is there a link? Epilepsia. 2020 Sep;61(9):1840-53. doi: 10.1111/epi.16656. Epub 2020 Sep 17.
6. McKee HR, Privitera MD. Stress as a seizure precipitant: Identification, associated factors, and treatment options. Seizure. 2017 Jan;44:21-6. doi: 10.1016/j.seizure.2016.12.009. Epub 2016 Dec 20.
7. Karlov VA, Burd SG, Lebedeva AV, et al. Epilepsy and COVID-19. Tactic and treatment. Recommendations of Russian League Against Epilepsy. Epilepsiya i paroksizmal'nyye sostoyaniya = Epilepsy and Paroxysmal Conditions. 2020;12(1):84-8. doi: 10.17749/2077-8333.2020.12.1.84-88 (In Russ.).
8. Safdarian AR, Momenzadeh K, Kahe F, et al. Death due to COVID-19 in a patient with diabetes, epilepsy, and gout comorbidities. Clin Case Rep. 2020 Nov 25;9(1):461-4. doi: 10.1002/ccr3.3557. Online ahead of print.
9. Fonseca E, Quintana M, Lallana S, et al. Epilepsy in time of COVID-19: A survey-based study. Acta Neurol Scand. 2020 Dec;142(6):545- 54. doi: 10.1111/ane.13335. Epub 2020 Sep 6.
10. Carroll E, Neumann H, Aguero-Rosenfeld ME, et al. Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus. Epilepsia. 2020 Oct;61(10):e135-e139. doi: 10.1111/epi.16683. Epub 2020 Sep 18.
11. Rosengard JL, Donato J, Ferastraoaru V, et al. Seizure control, stress, and access to care during the COVID-19 pandemic in New York City: The patient perspective. Epilepsia. 2021 Jan;62(1):41-50. doi: 10.1111/epi.16779. Epub 2020 Nov 30.
12. Leitinger M, Poppert K-N, Mauritz M, et al. Status epilepticus admissions during the COVID-19 pandemic in Salzburg – A population-based study. Epilepsia. 2020 Dec;61(12):e198-e203. doi: 10.1111/epi.16737. Epub 2020 Nov 2.
13. Ivanova NE, Kravtsova SV, Ivanov AYu, Odintsova GV. Epidemiology of epileptic status in women with epilepsy. Sovremennyye problemy nauki i obrazovaniya. 2018;(4). Available from: http://science-education.ru/ru/article/view?id=27842 (In Russ.).
14. Granata T, Bisulli F, Arzimanoglou A, Rocamora R. Did the COVID-19 pandemic silence the needs of people with epilepsy? Epileptic Disord. 2020 Aug 1;22(4):439-42. doi: 10.1684/epd.2020.1175
15. Odintsova GV, Aleksandrov MV, Uiitin AYu, Koloteva AV. Clinical features of neurosurgical epilepsy patients. Translyatsionnaya meditsina = Translational Medicine. 2018;5(2):30-7 (In Russ.).
16. Asadi-Pooya AA, Farazdaghi M, Bazrafshan M. Impacts of the COVID-19 pandemic on Iranian patients with epilepsy. Acta Neurol Scand. 2020 Oct;142(4):392-5. doi: 10.1111/ane.13310. Epub 2020 Jul 22.
17. Le Guennec L, Devianne J, Jalin L, et al. Orbitofrontal involvement in a neuroCOVID-19 patient. Epilepsia. 2020 Aug;61(8):e90-e94. doi: 10.1111/epi.16612. Epub 2020 Jul 23.
18. Medvedev VE, Dogotar OA. COVID-19 and mental health: challenges and first conclusions. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(6):4-10. doi: 10.14412/2074-2711-2020-6-4-10 (In Russ.).
19. Mosolov SN. Mental health problems in the context of the COVID-19 pandemic. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2020;120(5):7-15. doi: 10.17116/jnevro20201200517 (In Russ.).
20. Bachilo EV. Mental health of population during the COVID-19 pandemic. Zhurnal nevrologii i psikhiatrii im. SS Korsakova. 2020;120(10):130-6. doi: 10.17116/jnevro2020120101130 (In Russ.).
21. Dorozhenok IYu. Somatization disorders of affective and neurotic registers during the COVID-19 pandemic (analysis of clinical cases). Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(6):137-43. doi: 10.14412/2074-2711-2020-6-137-143 (In Russ.).
Review
For citations:
Odintsova G.V. COVID-19 and epilepsy: Russian and international experience. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(3):88-92. (In Russ.) https://doi.org/10.14412/2074-2711-2021-3-88-92
Views: 263
Email this article 